Thyroid Hormone Resistance (RTH): When the Body Doesn't Respond Normally to Thyroid Hormone

Thyroid hormone resistance (RTH) is a genetic condition where receptors don't respond normally to thyroid hormone. The lab pattern is high free T4 with an inappropriately normal or elevated TSH. Most patients need no treatment — the diagnosis matters mainly to prevent wrong therapy.

Why thyroid hormone resistance happens

In a normal thyroid axis, the pituitary gland senses circulating free T4 and free T3 and adjusts TSH up or down to keep hormone levels in range. The signal works because thyroid hormone binds to receptors inside cells — including pituitary cells — and shuts off TSH production. In resistance to thyroid hormone (RTH), those receptors are broken [C1][C3].

The most common form, RTHβ, is caused by a mutation in the THRB gene, which codes for the beta isoform of the thyroid hormone receptor. It is autosomal dominant — inherited from one parent — and a new mutation in the affected child explains roughly 15% of cases [C1][C3]. More than 170 different THRB mutations have been described, almost all clustered in three "hot spots" of the gene that disrupt how the receptor binds T3 [C3].

Because the receptor doesn't read the hormone signal correctly, the pituitary keeps making TSH even when T4 and T3 are high. The thyroid gland responds by producing more hormone. The system reaches a new equilibrium where everything is set higher — high free T4, often high free T3, and a TSH that is "inappropriately" normal or elevated [C1][C4].

A much rarer form, RTHα, is caused by mutations in the THRA gene (alpha receptor) and looks completely different: normal or low-normal T4, slightly raised T3, low reverse T3, and a clinical picture more like mild hypothyroidism with growth delay and constipation in childhood [C2][C5].

Clinical pattern: most patients look well

The defining feature of RTHβ is the mismatch between labs and symptoms [C1][C4]:

• Labs: free T4 elevated, often free T3 elevated, TSH not suppressed (typically 1–10 mIU/L). The combination of high free T4 + non-suppressed TSH is the diagnostic signature [C1][C2].
• Most patients: clinically euthyroid — the elevated hormone levels compensate for receptor resistance, so they feel and function essentially normally [C1][C4].
• Some patients: mixed picture — features of mild hyperthyroidism in tissues with normal receptors (heart, bone) and mild hypothyroidism in tissues that depend most on beta receptors (pituitary, liver) [C1][C3].

Goitre is present in around two-thirds of patients because of chronic TSH stimulation of the gland [C1][C4]. Common features that should raise suspicion include sinus tachycardia, attention-deficit traits, growth or hearing issues in childhood, or simply a goitre with otherwise puzzling labs [C1][C3]. Prevalence is around 1 in 40,000 births, though many cases go undiagnosed for years because the labs look paradoxical [C1].

What does NOT help — and what hurts

The single biggest risk in RTH is being treated for the wrong disease [C1][C4]. Three pitfalls are common:

• Antithyroid drugs, radioactive iodine, or thyroidectomy for assumed hyperthyroidism. These lower hormone levels that the patient actually needs — symptoms of hypothyroidism follow, and TSH rises further as the thyroid is destroyed [C1][C2][C4].
• Levothyroxine to "treat" the non-suppressed TSH as if it were primary hypothyroidism. Standard doses do not work because the receptors are resistant; doses high enough to suppress TSH can drive thyrotoxic effects in tissues with normal receptors [C2][C4].
• Beta-blockers as monotherapy for tachycardia without a confirmed diagnosis. Reasonable symptomatically, but they don't address the underlying picture and can mask the real diagnosis [C1].

The other important pitfall is the TSH-secreting pituitary adenoma (TSHoma) — a tumour that also produces high free T4 with a non-suppressed TSH. RTH and TSHoma look identical on a basic thyroid panel. Distinguishing them requires further testing (see below) because TSHoma is treated with surgery and RTH is not [C1][C2][C4].

How the diagnosis is confirmed

When the lab pattern is high free T4 with non-suppressed TSH, your endocrinologist will work through a stepwise differential [C1][C2][C4][C6]:

1. Rule out assay interference — biotin supplements, heterophile antibodies, and anti-streptavidin antibodies can produce a false high T4 / non-suppressed TSH pattern. Repeat with a different assay platform [C1][C2].
2. Check family members. RTH is autosomal dominant — finding the same lab pattern in a parent or sibling makes the diagnosis essentially certain [C1][C3].
3. Distinguish from TSHoma. Markers include serum alpha-subunit (raised in TSHoma, normal in RTH), pituitary MRI, and a TRH stimulation test (TSH rises in RTH, blunted response in TSHoma) [C1][C2][C4].
4. Genetic testing of THRB. Identifies a pathogenic variant in roughly 85% of clinically suspected RTH cases. A negative result does not exclude RTH — about 15% of patients have the same phenotype with no identifiable THRB mutation ("non-TR-RTH") [C1][C3].
5. Consider THRA testing if labs are atypical (low/normal T4, high T3, low rT3) or if the child has growth or skeletal features pointing to the alpha-receptor form [C2][C5].

Practical guidelines

1. Most patients need no treatment. Compensated euthyroid RTH is not a deficiency state — the elevated hormone levels are the body's adaptation [C1][C2][C4].
2. Avoid antithyroid drugs, RAI, and thyroidectomy in confirmed RTH. They worsen the picture and are the most common harm in this diagnosis [C1][C4].
3. Symptomatic tachycardia can be managed with a beta-blocker (e.g., atenolol) after diagnosis is confirmed [C1].
4. Children with growth, attention, or hearing concerns may benefit from selective use of triiodothyroacetic acid (TRIAC) under specialist care — it suppresses TSH without driving cardiac thyrotoxicosis. Initiated by an endocrinologist familiar with RTH, not by primary care [C1][C2].
5. Family screening. Once a THRB mutation is identified, first-degree relatives should have thyroid function tested and, if abnormal, genetic testing offered. This prevents repeat misdiagnoses across the family [C1][C2][C3].
6. Pregnancy planning. Each child of an affected parent has a 50% chance of inheriting the mutation. Maternal–fetal management is best done at a specialist centre — outcomes are generally good but require coordinated obstetric and endocrine care [C1][C2].

Frequently asked questions

Is RTH the same as hypothyroidism? No. In hypothyroidism, the thyroid gland doesn't make enough hormone, so TSH rises and free T4 falls. In RTH, the receptors don't respond properly, so the gland makes more hormone — TSH stays normal-to-high and free T4 is elevated [C1][C4].

Will levothyroxine fix RTH? Standard levothyroxine doses don't help compensated RTH and may cause symptoms by overshooting tissues with normal receptors. Levothyroxine has a role only in specific subtypes (e.g., after thyroid ablation, or in some forms of RTHα) under specialist guidance [C1][C2][C4].

Can RTH be cured? No — it's a lifelong genetic condition. The good news is that most patients live normal lives without treatment because their own elevated hormone levels compensate. Diagnosis exists mainly to prevent wrong treatment [C1][C4].

Should my children be tested? Yes. RTH is autosomal dominant, so each child has a 50% chance of inheriting the mutation. Testing prevents years of misdiagnosis if the labs ever come up flagged [C1][C2][C3].

Could a "high TSH and high T4" result just be a lab error? It's the first thing your endocrinologist will check. Biotin supplements, heterophile antibodies, and assay interference can produce the same pattern. Repeating on a different platform after stopping biotin for 72 hours is standard [C1][C2].

Bottom line

Resistance to thyroid hormone is a rare, mostly compensated genetic condition where the thyroid hormone receptor doesn't read its signal correctly [C1][C3]. The classic lab fingerprint is high free T4 with a non-suppressed TSH [C1][C2]. Most patients are clinically well and need no treatment — the harm comes from being misdiagnosed as Graves' disease, a TSH-secreting pituitary adenoma, or primary hypothyroidism [C1][C4]. Genetic testing of THRB (or THRA in atypical cases) confirms the diagnosis, and screening first-degree relatives prevents repeat misdiagnoses in the family [C2][C3]. If you have this lab pattern, your endocrinologist will work through the differential before any treatment is started [C2].